{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:34:26Z","timestamp":1792010066238,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.taap.2012.03.008","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T03:58:15Z","timestamp":1332475095000},"page":"294-302","source":"Crossref","is-referenced-by-count":55,"title":["Oral and inhaled corticosteroids: Differences in P-glycoprotein (ABCB1) mediated efflux"],"prefix":"10.1016","volume":"260","author":[{"given":"Andrew","family":"Crowe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai May","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2012.03.008_bb0005","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1211\/jpp.57.9.0010","article-title":"Brain permeability of inhaled corticosteroids","volume":"57","author":"Arya","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.taap.2012.03.008_bb0010","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1513\/pats.200402-014MS","article-title":"Corticosteroid resistance in airway disease","volume":"1","author":"Barnes","year":"2004","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.taap.2012.03.008_bb0015","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7326\/0003-4819-139-5_Part_1-200309020-00012","article-title":"How do corticosteroids work in asthma?","volume":"139","author":"Barnes","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.taap.2012.03.008_bb0020","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0140-6736(09)60326-3","article-title":"Glucocorticoid resistance in inflammatory diseases","volume":"373","author":"Barnes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2012.03.008_bb0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ibd.20640","article-title":"Budesonide induction and maintenance therapy for Crohn's disease during pregnancy","volume":"15","author":"Beaulieu","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.taap.2012.03.008_bb0030","doi-asserted-by":"crossref","first-page":"C1256","DOI":"10.1152\/ajpcell.2000.278.6.C1256","article-title":"Role of multidrug resistance P-glycoprotein in the secretion of aldosterone by human adrenal NCI-H295 cells","volume":"278","author":"Bello-Reuss","year":"2000","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.taap.2012.03.008_bb0260","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/thx.2006.073429","article-title":"Pathological features and inhaled corticosteroid response of response of eosinophilic and non-eosinophilic asthma","volume":"62","author":"Berry","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.taap.2012.03.008_bb0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2005.12.010","article-title":"Modulation of P-glycoprotein and breast cancer resistance protein by some prescribed corticosteroids","volume":"531","author":"Cooray","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2012.03.008_bb0045","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1472-9725.2004.00055.x","article-title":"Glucocorticoid-resistant asthma","volume":"4","author":"Corrigan","year":"2004","journal-title":"Clin. Exp. All Rev."},{"key":"10.1016\/j.taap.2012.03.008_bb0050","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0149-2918(01)80113-2","article-title":"A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate","volume":"9","author":"Crim","year":"2001","journal-title":"Clin. Ther."},{"key":"10.1016\/j.taap.2012.03.008_bb0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2008.06.090","article-title":"pH dependent efflux of methamphetamine derivatives and their reversal through human Caco-2 cell monolayers","volume":"592","author":"Crowe","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2012.03.008_bb0060","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/10611860600720814","article-title":"Limited P-glycoprotein mediated efflux for anti-epileptic drugs","volume":"14","author":"Crowe","year":"2006","journal-title":"J. Drug Target."},{"key":"10.1016\/j.taap.2012.03.008_bb0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v14.i3.20","article-title":"A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model","volume":"14","author":"Delie","year":"1997","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.taap.2012.03.008_bb0070","first-page":"327","article-title":"Corticosteroid pharmacokinetic\/pharmacodynamic parameters and their relationship to safety and efficacy","volume":"26","author":"Derendorf","year":"2005","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.taap.2012.03.008_bb0075","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/00054725-200409000-00012","article-title":"Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein","volume":"10","author":"Dilger","year":"2004","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.taap.2012.03.008_bb0080","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00003088-200140060-00004","article-title":"Clinical pharmacokinetics of inhaled budesonide","volume":"40","author":"Donnelly","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.taap.2012.03.008_bb0085","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2174\/138161211795428984","article-title":"Steroid resistance in severe asthma: current mechanisms and future treatment","volume":"17","author":"Durham","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.taap.2012.03.008_bb0090","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1742-7843.2006.pto_355.x","article-title":"Airway selectivity: an update of pharmacokinetic factors affecting local and systemic disposition of inhaled steroids","volume":"98","author":"Edsb\u00e4cker","year":"2006","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.taap.2012.03.008_bb0095","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1677\/joe.0.1780339","article-title":"Mechanisms of steroid action and resistance in inflammation","volume":"178","author":"Farrell","year":"2003","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.taap.2012.03.008_bb0100","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1677\/joe.0.1780339","article-title":"Glucocorticoid resistance in inflammatory bowel disease","volume":"178","author":"Farrell","year":"2003","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.taap.2012.03.008_bb0105","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1016\/j.bmc.2004.05.045","article-title":"Corticosteroids: the mainstay in asthma therapy","volume":"12","author":"Gupta","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.taap.2012.03.008_bb0110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1023\/A:1018825819249","article-title":"Evidence for different ABC-transporters in Caco-2 cells modulating drug uptake","volume":"16","author":"Gutmann","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.taap.2012.03.008_bb0265","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0022-3565(24)29493-3","article-title":"Multidrug resistance-associated protein-I functional activity in Calu-3 cells","volume":"298","author":"Hamilton","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2012.03.008_bb0120","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/thorax.58.3.258","article-title":"Plasma concentration of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects","volume":"58","author":"Harrison","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.taap.2012.03.008_bb0125","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2500\/105065897781446603","article-title":"Expression of P-glycoprotein 170 in nasal mucosa may be increased with topical steroids","volume":"11","author":"Henriksson","year":"1997","journal-title":"Am. J. Rhinol."},{"key":"10.1016\/j.taap.2012.03.008_bb0130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0022-3565(24)35286-3","article-title":"Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2)","volume":"292","author":"Hirohashi","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2012.03.008_bb0135","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1586\/ers.10.60","article-title":"Budesonide\/formoterol in the treatment of asthma","volume":"4","author":"Hodgson","year":"2010","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.taap.2012.03.008_bb0140","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.iac.2005.05.004","article-title":"Comparative pharmacology, bioavailability, pharmacokinetics, and pharmacodynamics of inhaled glucocorticosteroids","volume":"25","author":"H\u0171bner","year":"2005","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"10.1016\/j.taap.2012.03.008_bb0145","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1254\/jphs.10109FP","article-title":"Inhibition of P-glycoprotein-mediated efflux of digoxin and its metabolites by macrolide antibiotics","volume":"113","author":"Hughes","year":"2010","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.taap.2012.03.008_bb0150","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jaci.2006.01.032","article-title":"Update on glucocorticoid action and resistance","volume":"117","author":"Ito","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.taap.2012.03.008_bb0155","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/02770900902777767","article-title":"The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children","volume":"46","author":"Kopriva","year":"2009","journal-title":"J. Asthma"},{"key":"10.1016\/j.taap.2012.03.008_bb0160","first-page":"355","article-title":"Induction of drug-metabolising enzymes and transporters in human bronchial epithelial cells by beclomethasone dipropionate","volume":"56","author":"Kuzuya","year":"2004","journal-title":"Life"},{"key":"10.1016\/j.taap.2012.03.008_bb0165","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0006-2952(02)01156-5","article-title":"Transcriptional regulators of the human multidrug resistance 1 gene: recent views","volume":"64","author":"Labialle","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2012.03.008_bb0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cpem.2007.04.003","article-title":"Review of asthma: pathophysiology and current treatment options","volume":"8","author":"Linzer","year":"2007","journal-title":"Clin. Pediatr. Emerg. Med."},{"key":"10.1016\/j.taap.2012.03.008_bb0175","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1177\/00912709922011755","article-title":"P-glycoprotein and drug therapy in organ transplantation","volume":"39","author":"Lo","year":"1999","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2012.03.008_bb0180","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/sj.bjp.0706992","article-title":"Effects of budesonide on P-glycoprotein expression in intestinal cell lines","volume":"150","author":"Maier","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2012.03.008_bb0185","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/en.139.4.1789","article-title":"Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1a P-glycoprotein knockout mice","volume":"139","author":"Meijer","year":"1998","journal-title":"Endocrinol."},{"key":"10.1016\/j.taap.2012.03.008_bb0190","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4238\/vol8-2gmr574","article-title":"Effects of ABCB1 3435C>T genotype on serum levels of cortisol and aldosterone in women with normal menstrual cycles","volume":"8","author":"Nakamura","year":"2009","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.taap.2012.03.008_bb0195","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tox.2008.08.004","article-title":"Expression and induction by rifampicin of CAR- and PXR-regulated CYP2B and CYP3A in liver, kidney and airways of pig","volume":"252","author":"Nannelli","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2012.03.008_bb0200","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1248\/bpb.25.393","article-title":"Secretory transport of methylprednisolone possibly mediated by P-glycoprotein in Caco-2 cells","volume":"25","author":"Oka","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.taap.2012.03.008_bb0205","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0024-3205(02)02446-3","article-title":"Molecular mechanisms of corticosteroids actions in chronic inflammatory airway disease","volume":"72","author":"Pelaia","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2012.03.008_bb0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.2042-7158.2003.tb02434.x","article-title":"Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines","volume":"55","author":"Pfrunder","year":"2003","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.taap.2012.03.008_bb0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1021\/js970163u","article-title":"Involvement of intestinal P-glycoprotein in the restricted absorption of methylprednisolone from rat small intestine","volume":"87","author":"Saitoh","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.taap.2012.03.008_bb0220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.crohns.2010.10.004","article-title":"The use of cyclosporin A in acute steroid-refractory ulcerative colitis: long term outcomes","volume":"5","author":"Sharkey","year":"2011","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.taap.2012.03.008_bb0225","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1183\/09031936.97.10071640","article-title":"Glucocorticoid-resistant asthma: pathogenesis and clinical implications for management","volume":"10","author":"Szefler","year":"1997","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.taap.2012.03.008_bb0230","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/DDDT.S11290","article-title":"Current and emerging drugs for the treatment of inflammatory bowel disease","volume":"5","author":"Triantafillidis","year":"2011","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.taap.2012.03.008_bb0235","doi-asserted-by":"crossref","first-page":"24248","DOI":"10.1016\/S0021-9258(18)35757-0","article-title":"Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone","volume":"267","author":"Ueda","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2012.03.008_bb0240","doi-asserted-by":"crossref","first-page":"24248","DOI":"10.1016\/S0021-9258(18)35757-0","article-title":"Human P-glycoprotein transports cortisol, aldosterone, dexamethasone but not progesterone","volume":"267","author":"Ueda","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2012.03.008_bb0245","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1046\/j.1365-2826.2002.00836.x","article-title":"Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice-deficient for both mdr1a and mdr1b P-glycoproteins","volume":"14","author":"Uhr","year":"2002","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.taap.2012.03.008_bb0250","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1513\/pats.200403-025MS","article-title":"How the lungs handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids","volume":"1","author":"Winkler","year":"2004","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.taap.2012.03.008_bb0255","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1023\/B:PHAM.0000003377.39548.f6","article-title":"Structural determinants of P-glycoprotein-mediated transport of glucocorticoids","volume":"20","author":"Yates","year":"2003","journal-title":"Pharm. Res."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12001019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12001019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T20:10:10Z","timestamp":1742760610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X12001019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0041008X12001019"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2012.03.008","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}